3 ML ibandronic acid 1 MG/ML Prefilled Syringe — RxCUI 904952
RxNorm drug concept · Semantic clinical drug
RxCUI 904952
Semantic clinical drug · SCD
● Current RxNorm concept 2 FDA products
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI904952
Official name3 ML ibandronic acid 1 MG/ML Prefilled Syringe
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asibandronic acid 3 MG (as ibandronate sodium 3.39 MG) per 3 ML Prefilled Syringe; ibandronate sodium 3 MG in 3 ML Prefilled Syringe
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Ibandronate: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Ibandronate is a type of medication called a bisphosphonate. It works by slowing down the cells in your body that break down bone tissue, which helps your bones stay denser and str...
- What exactly is ibandronate and what is it supposed to do for me?
- There are a few key steps, and they really matter — skipping them can make the medication less effective or cause stomach and esophageal irritation. Take your tablet first thing in...
- How do I take the tablet correctly? I've heard there are a lot of rules.
🕸️ Concept Web — How 3 ML ibandronic acid 1 MG/ML Prefilled Syringe Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
3 ML ibandronic acid 1 MG/ML Prefilled Syringe
RxCUI 904952 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Ibandronate
115264IN -
Ibandronic acid
115265PIN
-
Ibandronate
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Boniva
541684BN
-
Boniva
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Ibandronate Prefilled Syringe
727807SCDF -
Ibandronic acid Prefilled Syringe
2647409SCDFP -
Ibandronate Injectable Product
1165296SCDG -
Ibandronic acid Injectable Product
2660557SCDGP -
Ibandronate Prefilled Syringe [Boniva]
728000SBDF -
Ibandronic acid Prefilled Syringe [Boniva]
2657594SBDFP -
Boniva Injectable Product
1175712SBDG -
Prefilled Syringe
721656DF - +1 more in this family
-
Ibandronate Prefilled Syringe
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Ibandronic acid 1 MG/ML
904951SCDC -
3 ML ibandronic acid 1 MG/ML Prefilled Syringe [Boniva]
904954SBD -
Ibandronic acid 1 MG/ML [Boniva]
904953SBDC
-
Ibandronic acid 1 MG/ML
Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Ibandronic acid 1 MG/ML
SCDC · 904951 -
Ibandronate Prefilled Syringe
SCDF · 727807 -
Ibandronic acid Prefilled Syringe
SCDFP · 2647409 -
Ibandronate Injectable Product
SCDG · 1165296 -
Ibandronic acid Injectable Product
SCDGP · 2660557
Brand-Name Concepts
-
3 ML ibandronic acid 1 MG/ML Prefilled Syringe [Boniva]
SBD · 904954 -
Ibandronic acid 1 MG/ML [Boniva]
SBDC · 904953 -
Ibandronate Prefilled Syringe [Boniva]
SBDF · 728000 -
Ibandronic acid Prefilled Syringe [Boniva]
SBDFP · 2657594 -
Boniva Injectable Product
SBDG · 1175712 -
Boniva
BN · 541684
📦 FDA Products & Package NDCs
2 products · 2 package NDCs
2 package NDCs map to RxCUI 904952 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 55150-0191-83 | 1 SYRINGE, GLASS in 1 CARTON (55150-191-83) / 3 mL in 1 SYR... | Ibandronate Sodium | Eugia US LLC | 2015-08-19 |
| 60505-6097-00 | 1 SYRINGE, GLASS in 1 CARTON (60505-6097-0) / 3 mL in 1 SYR... | Ibandronate Sodium | Apotex Corp. | 2016-01-13 |
Observed labelers:
Apotex Corp. (1) ·
Eugia US LLC (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J1740 | Ibandronate sodium injection | 2 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.